{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T15:29:29Z","timestamp":1791646169944,"version":"4.3.4"},"reference-count":45,"publisher":"Japanese Circulation Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2026,6,25]]},"DOI":"10.1253\/circj.cj-25-0791","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T22:08:35Z","timestamp":1771970915000},"page":"835-844","source":"Crossref","is-referenced-by-count":2,"title":["Ischemic and Bleeding Events After Early Initiation of Direct Oral Anticoagulants for Acute Intracranial Hemorrhage With Non-Valvular Atrial Fibrillation\u3000\u2015 A Multicenter Prospective Registry \u2015"],"prefix":"10.1253","volume":"90","author":[{"given":"Masatoshi","family":"Koga","sequence":"first","affiliation":[{"name":"Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Toyoda","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Iguchi","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Jikei University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Itabashi","sequence":"additional","affiliation":[{"name":"Stroke Center, Division of Neurology and Gerontology, Department of Internal Medicine, School of Medicine, Iwate Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroharu","family":"Kataoka","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michikazu","family":"Nakai","sequence":"additional","affiliation":[{"name":"Clinical Research Support Center, University of Miyazaki Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanta","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaori","family":"Miwa","sequence":"additional","affiliation":[{"name":"Department of Cerebrovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rei","family":"Kondo","sequence":"additional","affiliation":[{"name":"Stroke Center, Yamagata City Hospital Saiseikan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatemi","family":"Todaka","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Japanese Red Cross Kumamoto Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoto","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Iwate Prefectural Central Hospital"},{"name":"Department of Neurosurgery, Nansho Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunikazu","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kansai Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Yamashiro","sequence":"additional","affiliation":[{"name":"Division of Neurosurgery, Department of Cerebrovascular Medicine and Surgery, Saiseikai Kumamoto Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Ogishima","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Japanese Red Cross Musashino Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Terasawa","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Brain Attack Center Ota Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobukazu","family":"Komoribayashi","sequence":"additional","affiliation":[{"name":"Iwate Prefectural Advanced Critical Care and Emergency Center, Iwate Medical University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Sakai","sequence":"additional","affiliation":[{"name":"Department of Neurovascular Research, Kobe City Medical Center General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taketo","family":"Hatano","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kokura Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Arakawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Steel Memorial Yawata Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazutaka","family":"Sonoda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Saiseikai Fukuoka General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joji","family":"Hagii","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Hirosaki Stroke and Rehabilitation Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruyuki","family":"Hirano","sequence":"additional","affiliation":[{"name":"Department of Stroke and Cerebrovascular Medicine, Kyorin University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Miyashita","sequence":"additional","affiliation":[{"name":"Division of Neurology, Kagoshima City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Ohnishi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Ohnishi Neurological Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Kimura","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medicine, Nippon Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Neuro-endovascular Therapy, Stroke Center, St. Marianna University Toyoko Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiko","family":"Maezono-Kandori","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kyoto Second Red Cross Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukako","family":"Yazawa","sequence":"additional","affiliation":[{"name":"Department of Stroke Neurology, Kohnan Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanori","family":"Kinosada","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Kurashiki Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Izumo","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Gifu University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouhei","family":"Noshiro","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Obihiro Kosei Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hikaru","family":"Nagasawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, Yamagata Prefectural Central Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuniyasu","family":"Wada","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kumamoto City Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Yamagami","sequence":"additional","affiliation":[{"name":"Department of Stroke Neurology, NHO Osaka National Hospital"},{"name":"Division of Stroke Prevention and Treatment, Institute of Medicine, University of Tsukuba"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Kamiyama","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Nakamura Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Takagi","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Tokushima University Graduate School of Biomedical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Neurology, TOYOTA Memorial Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Sugio","sequence":"additional","affiliation":[{"name":"Primary Medical Science Department, Daiichi Sankyo Co. Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Takita","sequence":"additional","affiliation":[{"name":"Data Intelligence Department, Daiichi Sankyo Co. Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Kimura","sequence":"additional","affiliation":[{"name":"Medical Affairs Planning Department, Daiichi Sankyo Co. Ltd."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Unverdorben","sequence":"additional","affiliation":[{"name":"Daiichi Sankyo, Inc."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Ihara","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Cerebral and Cardiovascular Center"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Fujimoto","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jichi Medical University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashkan","family":"Shoamanesh","sequence":"additional","affiliation":[{"name":"Department of Medicine, Population Health Research Institute, McMaster University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the SAFE-ICH Registry Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","unstructured":"1. World Health Organization. The top 10 causes of death. 2024. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/the-top-10-causes-of-death (accessed February 27, 2025)."},{"key":"2","unstructured":"2. Ministry of Health, Labour and Welfare. Summary of monthly vital statistics annual report (approximate figures). 2022. https:\/\/www.mhlw.go.jp\/toukei\/saikin\/hw\/jinkou\/geppo\/nengai22\/dl\/gaikyouR4.pdf (accessed March 2, 2024)."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Shen AY, Yao JF, Brar SS, Jorgensen MB, Chen W. Racial\/ethnic differences in the risk of intracranial hemorrhage among patients with atrial fibrillation. <i>J Am Coll Cardiol<\/i> 2007; 50: 309\u2013315, doi:10.1016\/j.jacc.2007.01.098.","DOI":"10.1016\/j.jacc.2007.01.098"},{"key":"4","doi-asserted-by":"publisher","unstructured":"4. Toyoda K, Yoshimura S, Nakai M, Koga M, Sasahara Y, Sonoda K, et al. Twenty-year change in severity and outcome of ischemic and hemorrhagic strokes. <i>JAMA Neurology<\/i> 2022; 79: 61\u201369, doi:10.1001\/jamaneurol.2021.4346.","DOI":"10.1001\/jamaneurol.2021.4346"},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Horstmann S, Rizos T, Jenetzky E, Gumbinger C, Hacke W, Veltkamp R. Prevalence of atrial fibrillation in intracerebral hemorrhage. <i>Eur J Neurol<\/i> 2014; 21: 570\u2013576, doi:10.1111\/ene.12215.","DOI":"10.1111\/ene.12215"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Overvad TF, Andersen SD, Larsen TB, Lip GYH, S\u00f8gaard M, Skj\u00f8th F, et al. Incidence and prognostic factors for recurrence of intracerebral hemorrhage in patients with and without atrial fibrillation: A cohort study. <i>Thromb Res<\/i> 2020; 191: 1\u20138, doi:10.1016\/j.thromres.2020.03.024.","DOI":"10.1016\/j.thromres.2020.03.024"},{"key":"7","unstructured":"7. Tenny S, Das JM, Thorell W. Intracranial hemorrhage. <i>In<\/i>: StatPearls. StatPearls Publishing, 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK470242\/ (accessed January 27, 2026)."},{"key":"8","doi-asserted-by":"publisher","unstructured":"8. Zathar Z, Karunatilleke A, Fawzy AM, Lip GYH. Atrial fibrillation in older people: Concepts and controversies. <i>Front Med (Lausanne)<\/i> 2019; 6: 175, doi:10.3389\/fmed.2019.00175.","DOI":"10.3389\/fmed.2019.00175"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Katsanos AH, Kamel H, Healey JS, Hart RG. Stroke prevention in atrial fibrillation: Looking forward. <i>Circulation<\/i> 2020; 142: 2371\u20132388, doi:10.1161\/circulationaha.120.049768.","DOI":"10.1161\/CIRCULATIONAHA.120.049768"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, et al. Edoxaban versus warfarin in patients with atrial fibrillation. <i>N Engl J Med<\/i> 2013; 369: 2093\u20132104, doi:10.1056\/NEJMoa1310907.","DOI":"10.1056\/NEJMoa1310907"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Granger CB, Alexander JH, McMurray JJ, Lopes RD, Hylek EM, Hanna M, et al. Apixaban versus warfarin in patients with atrial fibrillation. <i>N Engl J Med<\/i> 2011; 365: 981\u2013992, doi:10.1056\/NEJMoa1107039.","DOI":"10.1056\/NEJMoa1107039"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Patel MR, Mahaffey KW, Garg J, Pan G, Singer DE, Hacke W, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. <i>N Engl J Med<\/i> 2011; 365: 883\u2013891, doi:10.1056\/NEJMoa1009638.","DOI":"10.1056\/NEJMoa1009638"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, et al. Dabigatran versus warfarin in patients with atrial fibrillation. <i>N Engl J Med<\/i> 2009; 361: 1139\u20131151, doi:10.1056\/NEJMoa0905561.","DOI":"10.1056\/NEJMoa0905561"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Li L, Murthy SB. Cardiovascular events after intracerebral hemorrhage. <i>Stroke<\/i> 2022; 53: 2131\u20132141, doi:10.1161\/STROKEAHA.122.036884.","DOI":"10.1161\/STROKEAHA.122.036884"},{"key":"15","doi-asserted-by":"publisher","unstructured":"15. Sennfalt S, Norrving B, Petersson J, Ullberg T. Long-term survival and function after stroke: A longitudinal observational study from the Swedish stroke register. <i>Stroke<\/i> 2019; 50: 53\u201361, doi:10.1161\/STROKEAHA.118.022913.","DOI":"10.1161\/STROKEAHA.118.022913"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Al-Shahi Salman R, Stephen J, Tierney JF, Lewis SC, Newby DE, Parry-Jones AR, et al. Effects of oral anticoagulation in people with atrial fibrillation after spontaneous intracranial haemorrhage (COCROACH): Prospective, individual participant data meta-analysis of randomised trials. <i>Lancet Neurol<\/i> 2023; 22: 1140\u20131149, doi:10.1016\/S1474-4422(23)00315-0.","DOI":"10.1016\/S1474-4422(23)00315-0"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17. Hawryluk GW, Austin JW, Furlan JC, Lee JB, O\u2019Kelly C, Fehlings MG. Management of anticoagulation following central nervous system hemorrhage in patients with high thromboembolic risk. <i>J Thromb Haemost<\/i> 2010; 8: 1500\u20131508, doi:10.1111\/j.1538-7836.2010.03882.x.","DOI":"10.1111\/j.1538-7836.2010.03882.x"},{"key":"18","doi-asserted-by":"publisher","unstructured":"18. Majeed A, Kim YK, Roberts RS, Holmstr\u00f6m M, Schulman S. Optimal timing of resumption of warfarin after intracranial hemorrhage. <i>Stroke<\/i> 2010; 41: 2860\u20132866, doi:10.1161\/strokeaha.110.593087.","DOI":"10.1161\/STROKEAHA.110.593087"},{"key":"19","doi-asserted-by":"publisher","unstructured":"19. Ahmed N, Audebert H, Turc G, Cordonnier C, Christensen H, Sacco S, et al. Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11\u201313 November 2018. <i>Eur Stroke J<\/i> 2019; 4: 307\u2013317, doi:10.1177\/2396987319863606.","DOI":"10.1177\/2396987319863606"},{"key":"20","doi-asserted-by":"publisher","unstructured":"20. Greenberg SM, Ziai WC, Cordonnier C, Dowlatshahi D, Francis B, Goldstein JN, et al. 2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: A guideline from the American Heart Association\/American Stroke Association. <i>Stroke<\/i> 2022; 53: e282\u2013e361, doi:10.1161\/STR.0000000000000407.","DOI":"10.1161\/STR.0000000000000407"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the Diagnosis and Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. <i>Eur Heart J<\/i> 2021; 42: 373\u2013498, doi:10.1093\/eurheartj\/ehaa612.","DOI":"10.1093\/eurheartj\/ehaa612"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Lip GYH, Banerjee A, Boriani G, Chiang CE, Fargo R, Freedman B, et al. Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report. <i>Chest<\/i> 2018; 154: 1121\u20131201, doi:10.1016\/j.chest.2018.07.040.","DOI":"10.1016\/j.chest.2018.07.040"},{"key":"23","doi-asserted-by":"publisher","unstructured":"23. Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeusler KG, et al. 2021 European Heart Rhythm Association practical guide on the use of non-vitamin k antagonist oral anticoagulants in patients with atrial fibrillation. <i>EP Europace<\/i> 2021; 23: 1612\u20131676, doi:10.1093\/europace\/euab065.","DOI":"10.1093\/europace\/euab065"},{"key":"24","doi-asserted-by":"publisher","unstructured":"24. Tomaselli GF, Mahaffey KW, Cuker A, Dobesh PP, Doherty JU, Eikelboom JW, et al. 2017 ACC expert consensus decision pathway on management of bleeding in patients on oral anticoagulants: A report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. <i>J Am Coll Cardiol<\/i> 2017; 70: 3042\u20133067, doi:10.1016\/j.jacc.2017.09.1085.","DOI":"10.1016\/j.jacc.2017.09.1085"},{"key":"25","doi-asserted-by":"publisher","unstructured":"25. Steiner T, Al-Shahi Salman R, Beer R, Christensen H, Cordonnier C, Csiba L, et al. European Stroke Organisation (ESO) guidelines for the management of spontaneous intracerebral hemorrhage. <i>Int J Stroke<\/i> 2014; 9: 840\u2013855, doi:10.1111\/ijs.12309.","DOI":"10.1111\/ijs.12309"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Shoamanesh A, Lindsay MP, Castellucci LA, Cayley A, Crowther M, de Wit K, et al. Canadian stroke best practice recommendations: Management of Spontaneous Intracerebral Hemorrhage, 7th edition update 2020. <i>Int J Stroke<\/i> 2021; 16: 321\u2013341, doi:10.1177\/1747493020968424.","DOI":"10.1177\/1747493020968424"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Xu Y, Shoamanesh A, Schulman S, Dowlatshahi D, Al-Shahi Salman R, Moldovan ID, et al. Oral anticoagulant re-initiation following intracerebral hemorrhage in non-valvular atrial fibrillation: Global survey of the practices of neurologists, neurosurgeons and thrombosis experts. <i>PLoS One<\/i> 2018; 13: e0191137, doi:10.1371\/journal.pone.0191137.","DOI":"10.1371\/journal.pone.0191137"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Miyamoto S, Ogasawara K, Kuroda S, Itabashi R, Toyoda K, Itoh Y, et al. Japan Stroke Society guideline 2021 for the treatment of stroke. <i>Int J Stroke<\/i> 2022; 17: 1039\u20131049, doi:101177\/17474930221090347.","DOI":"10.1177\/17474930221090347"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29. Maeda K, Koga M, Okada Y, Kimura K, Yamagami H, Okuda S, et al. Nationwide survey of neuro-specialists\u2019 opinions on anticoagulant therapy after intracerebral hemorrhage in patients with atrial fibrillation. <i>J Neurol Sci<\/i> 2012; 312: 82\u201385, doi:10.1016\/j.jns.2011.08.017.","DOI":"10.1016\/j.jns.2011.08.017"},{"key":"30","doi-asserted-by":"publisher","unstructured":"30. Sakamoto Y, Nito C, Nishiyama Y, Suda S, Matsumoto N, Aoki J, et al. Safety of anticoagulant therapy including direct oral anticoagulants in patients with acute spontaneous intracerebral hemorrhage. <i>Circ J<\/i> 2019; 83: 441\u2013446, doi:10.1253\/circj.CJ-18-0938.","DOI":"10.1253\/circj.CJ-18-0938"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Suda S, Iguchi Y, Yagita Y, Kanzawa T, Okubo S, Fujimoto S, et al. Resumption of oral anticoagulation in patients with non-valvular atrial fibrillation after intracerebral hemorrhage: A sub-analysis of the PASTA Registry Study. <i>J Neurol Sci<\/i> 2023; 453: 120810, doi:10.1016\/j.jns.2023.120810.","DOI":"10.1016\/j.jns.2023.120810"},{"key":"32","doi-asserted-by":"publisher","unstructured":"32. Rodeghiero F, Tosetto A, Abshire T, Arnold DM, Coller B, James P, et al. ISTH\/SSC bleeding assessment tool: A standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders. <i>J Thromb Haemost<\/i> 2010; 8: 2063\u20132065, doi:10.1111\/j.1538-7836.2010.03975.x.","DOI":"10.1111\/j.1538-7836.2010.03975.x"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Kothari RU, Brott T, Broderick JP, Barsan WG, Sauerbeck LR, Zuccarello M, et al. The ABCs of measuring intracerebral hemorrhage volumes. <i>Stroke<\/i> 1996; 27: 1304\u20131305, doi:10.1161\/01.str.27.8.1304.","DOI":"10.1161\/01.STR.27.8.1304"},{"key":"34","doi-asserted-by":"publisher","unstructured":"34. Yamashita T, Akao M, Atarashi H, Ikeda T, Koretsune Y, Okumura K, et al. Causes of death in elderly patients with non-valvular atrial fibrillation: Results from the ANAFIE Registry. <i>Circ J<\/i> 2023; 87: 957\u2013963, doi:10.1253\/circj.CJ-22-0614.","DOI":"10.1253\/circj.CJ-22-0614"},{"key":"35","doi-asserted-by":"publisher","unstructured":"35. Puy L, Forman R, Cordonnier C, Sheth KN. Protecting the brain, from the heart: Safely mitigating the consequences of thrombosis in intracerebral hemorrhage survivors with atrial fibrillation. <i>Stroke<\/i> 2022; 53: 2152\u20132160, doi:10.1161\/STROKEAHA.122.036888.","DOI":"10.1161\/STROKEAHA.122.036888"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36. Chiang CE, Okumura K, Zhang S, Chao TF, Siu CW, Lim TW, et al. 2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation. <i>J Arrhythm<\/i> 2017; 33: 345\u2013367, doi:10.1016\/j.joa.2017.05.004.","DOI":"10.1016\/j.joa.2017.05.004"},{"key":"37","doi-asserted-by":"publisher","unstructured":"37. Pennlert J, Overholser R, Asplund K, Carlberg B, Van Rompaye B, Wiklund PG, et al. Optimal timing of anticoagulant treatment after intracerebral hemorrhage in patients with atrial fibrillation. <i>Stroke<\/i> 2017; 48: 314\u2013320, doi:10.1161\/strokeaha.116.014643.","DOI":"10.1161\/STROKEAHA.116.014643"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38. Ottosen TP, Grijota M, Hansen ML, Brandes A, Damgaard D, Husted SE, et al. Use of antithrombotic therapy and long-term clinical outcome among patients surviving intracerebral hemorrhage. <i>Stroke<\/i> 2016; 47: 1837\u20131843, doi:10.1161\/strokeaha.116.012945.","DOI":"10.1161\/STROKEAHA.116.012945"},{"key":"39","doi-asserted-by":"publisher","unstructured":"39. Park YA, Uhm JS, Pak HN, Lee MH, Joung B. Anticoagulation therapy in atrial fibrillation after intracranial hemorrhage. <i>Heart Rhythm<\/i> 2016; 13: 1794\u20131802, doi:10.1016\/j.hrthm.2016.05.016.","DOI":"10.1016\/j.hrthm.2016.05.016"},{"key":"40","doi-asserted-by":"publisher","unstructured":"40. Nielsen PB, Larsen TB, Skj\u00f8th F, Gorst-Rasmussen A, Rasmussen LH, Lip GY. Restarting anticoagulant treatment after intracranial hemorrhage in patients with atrial fibrillation and the impact on recurrent stroke, mortality, and bleeding: A nationwide cohort study. <i>Circulation<\/i> 2015; 132: 517\u2013525, doi:10.1161\/circulationaha.115.015735.","DOI":"10.1161\/CIRCULATIONAHA.115.015735"},{"key":"41","doi-asserted-by":"publisher","unstructured":"41. Veltkamp R, Korompoki E, Harvey KH, Harvey ER, Fiessler C, Malzahn U, et al. Direct oral anticoagulants versus no anticoagulation for the prevention of stroke in survivors of intracerebral haemorrhage with atrial fibrillation (PRESTIGE-AF): A multicentre, open-label, randomised, phase 3 trial. <i>Lancet<\/i> 2025; 405: 927\u2013936, doi:10.1016\/S0140-6736(25)00333-2.","DOI":"10.1016\/S0140-6736(25)00333-2"},{"key":"42","doi-asserted-by":"publisher","unstructured":"42. Shiozawa M, Koga M, Inoue H, Yamashita T, Yasaka M, Suzuki S, et al. Risk of both intracranial hemorrhage and ischemic stroke in elderly individuals with nonvalvular atrial fibrillation taking direct oral anticoagulants compared with warfarin: Analysis of the ANAFIE registry. <i>Int J Stroke<\/i> 2023; 18: 986\u2013995, doi:10.1177\/17474930231175807.","DOI":"10.1177\/17474930231175807"},{"key":"43","doi-asserted-by":"publisher","unstructured":"43. Yakushiji Y, Tanaka J, Wilson D, Charidimou A, Noguchi T, Kawashima M, et al. Proportion of intracerebral haemorrhage due to cerebral amyloid angiopathy in the East and West: Comparison between single hospital centres in Japan and the United Kingdom. <i>J Neurol Sci<\/i> 2020; 416: 117037, doi:10.1016\/j.jns.2020.117037.","DOI":"10.1016\/j.jns.2020.117037"},{"key":"44","doi-asserted-by":"publisher","unstructured":"44. Shoamanesh A; ENRICH-AF Steering Committee. Anticoagulation in patients with cerebral amyloid angiopathy. <i>Lancet<\/i> 2023; 402: 1418\u20131419, doi:10.1016\/S0140-6736(23)02025-1.","DOI":"10.1016\/S0140-6736(23)02025-1"},{"key":"45","doi-asserted-by":"publisher","unstructured":"45. Toyoda K, Arakawa S, Ezura M, Kobayashi R, Tanaka Y, Hasegawa S, et al. Andexanet alfa for the reversal of Factor Xa inhibitor activity: Prespecified subgroup analysis of the ANNEXA-4 study in Japan. <i>J Atheroscler Thromb<\/i> 2024; 31: 201\u2013213, doi:10.5551\/jat.64223.","DOI":"10.5551\/jat.64223"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/7\/90_CJ-25-0791\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T03:23:12Z","timestamp":1782530592000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/90\/7\/90_CJ-25-0791\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":45,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-25-0791","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"article-number":"CJ-25-0791"}}